 sequenti administr recombin human dacarbazin metastat melanoma multicent phase II studi twenty-f assess patient metastat melanoma multicent phase II studi induct cycl human recombin continu intraven IV infus day day dacarbazin dtic IV bolu day cycl week mainten therapi week complet induct treatment day dtic IV week total week patient complet partial stabl diseas patient none patient site metastas maximum respons first month treatment progression-fre period month complet respond month partial respond month patient stabl diseas month toxic fever skin rash fatigu anorexia diarrhea patient patient weight gain patient intens care observ treatment myocardi injuri patient ventricular tachycardia hypotens oliguria sepsi sequenti treatment dtic effect